Simplify Logo

Full-Time

Bioinformatics Associate

Confirmed live in the last 24 hours

BillionToOne

BillionToOne

201-500 employees

Molecular diagnostics for prenatal and oncology testing

Biotechnology
Healthcare

Compensation Overview

$70k - $80kAnnually

+ Equity Options + Healthcare Options + 401k Match + Paid Parental Leave

Entry

Menlo Park, CA, USA

Category
Bioinformatics
Biology & Biotech
Required Skills
Python
Requirements
  • BS or MS in Bioinformatics, Computational Biology, Computer Science, Bioengineering, Physics or related field
  • Very strong programming skills in Python
  • High mathematical and statistical aptitude - must be able to reason from first principles
  • Great attention to detail
  • Can work in the United States without immediate sponsorship (Post-graduation OPT is acceptable)
Responsibilities
  • Develop sophisticated and robust next-generation sequencing analysis pipelines under the guidance of a senior scientist
  • Perform analysis of clinical bioinformatics data
  • Assemble and analyze quality metrics from the clinical laboratory
  • Collaborate with scientists and support new scientific insights

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair level, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne's business model centers on providing these diagnostic services directly to healthcare providers, generating revenue through the sale of their testing services. The goal of BillionToOne is to enhance the accuracy, efficiency, and accessibility of molecular testing, driven by a commitment to growth, equality, and teamwork in making a positive impact on healthcare.

Company Stage

Series C

Total Funding

$295.9M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

10%

1 year growth

25%

2 year growth

78%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $130M Series D funding round, led by PremjiInvest, positions BillionToOne for significant growth and expansion.
  • Partnerships with major companies like Johnson & Johnson enhance their credibility and market reach.
  • The appointment of Ross Taylor as CFO brings seasoned financial leadership, supporting the company's hypergrowth trajectory.

What critics are saying

  • The competitive landscape in molecular diagnostics is intense, requiring continuous innovation to maintain a leading position.
  • Dependence on healthcare providers for revenue could be impacted by changes in healthcare policies or economic downturns.

What makes BillionToOne unique

  • BillionToOne's QCT technology offers single base-pair resolution, providing unparalleled accuracy in molecular diagnostics.
  • Their focus on both prenatal screening and oncology testing allows them to address critical healthcare needs with specialized products like Northstar Select™ and Northstar Response™.
  • The company's mission-driven culture and commitment to accessibility set them apart in the biotech industry.

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging